DWTX
Dogwood Therapeutics, Inc.
NASDAQ: DWTX · HEALTHCARE · BIOTECHNOLOGY
$1.43
+5.93% today
Updated 2026-04-30
Market cap
$46.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-7.13
Dividend yield
—
52W range
$1 – $10
Volume
0.1M
Dogwood Therapeutics, Inc. (DWTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $65935.00 | $315900.00 | $31.47M | $15.78M | $8.37M | $4.17M | $94.31M |
| Cash & equivalents | $30026.00 | $309384.00 | $29.80M | $14.01M | $7.03M | $3.32M | $14.85M |
| Current assets | $42398.00 | $315900.00 | $31.47M | $15.78M | $8.37M | $4.17M | $16.54M |
| Total liabilities | $1.33M | $5.26M | $1.53M | $1.28M | $1.04M | $358548.00 | $30.03M |
| Current liabilities | $1.33M | $1.62M | $1.53M | $1.28M | $1.04M | $358548.00 | $3.18M |
| Long-term debt | — | — | — | — | — | — | $15.38M |
| Shareholder equity | $-1.26M | $-4.94M | $29.94M | $14.50M | $7.33M | $3.81M | $64.28M |
| Retained earnings | $-15.15M | $-17.62M | $-27.97M | $-43.93M | $-56.17M | $-61.47M | $-73.82M |
| Accounts receivable | $334.00 | $785.00 | $324.00 | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | $0.00 | $11.81M |